iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: Understanding the interface between physiology and disease

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Martin, Bronwen ^a   Brenneman, Randall ^a   Becker, Kevin G ^a   Gucek, Marjan ^b   Cole, Robert N ^b   Maudsley, Stuart ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PROTEOME; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; HIPPOCAMPUS; ISOTOPE LABELING; MICROTUBULE; MOUSE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; TAUOPATHY; UNINDEXED SEQUENCE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; METHODOLOGY; TRANSGENIC MOUSE;

ANIMALIA; MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULES; MODELS, BIOLOGICAL; NEURONAL PLASTICITY; PRESENILIN-1; PROTEOMICS; TAU PROTEINS;

EID: 50249099760     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002750     Document Type: Article

References (55)

1. Ashford JW (2004) APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci 23: 157-165.
2. Braak H, Braak E, Grundke-Iqbal I, Iqbal K (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65: 351-355.
3. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498.
4. Trojanowski JQ, Shin RW, Schmidt ML, Lee VM (1995) Relationship between plaques, tangles and dystrophic processes in Alzheimer's disease. Neurobiol Aging 16: 335-340.
5. Masliah E (1995) The natural evolution of the neurodegenerative alterations in Alzheimer's disease. Neurobiol Aging 16: 280-282.
6. Hashimoto M, Masliah E (2003) Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies. Neurochem Res 28: 1743-1756.
7. Hyman B, Gomez-Isla T (1991) Alzheimer's disease is a laminar regional and neural system specific disease, not a global brain disease. Neurobiol Aging 15: 353-354.
8. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT 2002 Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103: 26-35.
9. Braak H, Braak E (1996) Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 9: 1107-1119.
10. Minoshima S, Froster NL, Kuhl DE (1994) Posterior cingulate cortex in Alzheimer's disease. Lancet 341: 895.
11. Zola-Morgan S, Squire LR, Amaral DG (1989) Lesions of the hippocampal formation but not lesions of the fornix or the mammillary nuclei produce long-lasting memory impairment in monkeys. J Neurosci 9: 898-913.
12. Dekosky ST, Schell SW, Styren SD (1996) Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5: 417-421.
13. Schell SW, Price DA (2003) Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24: 1029-1046.
14. Masliah E (2001) Recent advances in the understanding of the role of synaptic proteins in Alzheimer's disease and other neurodegenerative disorders. J Alzheimer's Dis 3: 1-9.
15. Mattsuo MP (2001) Pathways towards and away from Alzheimer's disease. Nature 130: 631-639.
16. Roberson ED, Mucke L (2006) 100 years and counting: prospects for defeating Alzheimer's disease. Science 311: 781-784.
17. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
18. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: air integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: 711-718.
19. Churchill GA, Oliver B (2001) Sex, flies and microarrays. Nat Genet 29: 355-356.
20. Kendziorski C , Irizarry RA, Chen KS, Haaj JD, Gould MN (2005) On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci USA 102: 4252-4257.
21. Zhang SD, Gant TW (2004) A statistical framework for the design or microarray experiments and effective detection of differential gene expression. Bioinformatics 20: 2821-2828.
22. Praticò D, Uryu K, Leight S, Trojanoswki JQ Lee VM (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21: 4183-4187.
23. Butterfield DA, Sultana R (2007) Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 12: 61-72.
24. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, et al. (2005) S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siahl binding. Nat Cell Biol 7: 665-674.
25. Minger ST, Honer WG, Esiri MM, McDonald B, Keene J, et al. (2001) Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol 60: 929-936.
26. Bailey JA, Lahiri DK (2006) Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons: implications in neuronal plasticity and Alzheimer's disease. Ann NY Acad Sci 1086: 54-56.
27. Attems J, Quass M, Jellinger KA (2007) Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathol 113: 53-62.
28. Kelly BL, Ferreira A (2007) Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience 147: 60-70.
29. Zhang EY, DeTure MA, Bubb MR, Caviston TL, Erdos GW, et al. (1996) Self-assembly of the brain MAP-2 microtubule biding region into polymeric structures resembling Alzheimer filaments. Biochem Biophys Res Commun 229: 176-181.
30. Kovacs GG, Laszlo L, Kovacs J, Jensen PH, Lindersson E, et al. (2004) Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol Dis 17: 155-162.
31. Sugimori K, Kobayashi K, Kitmura T, Sudo S, Koshino Y (2007) 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease. Psychiatry Clin Neurosci 61: 159-167.
32. Alliegro MC (2000) A C-terminal carbohydrate-binding domain in the endothelial cell regulatory protein, pigpen: new function for an EWS family member. Exp Cell Res 255: 270-277.
33. Allapatt SR, Zhang M, Zhao X, Alliegro MA, Alliegro, et al. (2003) Mouse pigpen encodes a nuclear protein whose expression is developmentally regulated during craniofacial morphogenesis. Dev Dyn 228: 59-71.
34. Barbaccia ML, Costa E, Ferrero P, Guidotti A, Roy A, et al. (1986) Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia and Alzheimer's disease. Arch Gen Psychiatry 43: 1143-1147.
35. Ferrero P, Benna P, Costa P, Tarenzi L, Baggio G, et al. (1988) Diazepam binding inhibitor-like immunoreactivity (DBI-LI) in human CS. Correlations with neurological disorders. J Neurol Sci 87: 327-349.
36. Edgar PF, Schonberger SJ, Dean B, Faull RL, Kydd R, et al. (1999) A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol Psychiatry 4: 173-178.
37. Cello MR (1986) Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex. Science 231: 995-997.
38. Leifer D, Kowall NW (1993) Immunohistochemical patterns of selective cellular vulnerability in human cerebral ischemia. J Neurol Sci 119: 217-228.
39. Sloviter RS, Sollas AL, Barbaro NM, Laxer KD (1991) Calcium-biding protein (calbindin-D28k) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J Comp Neurol 308: 381-396.
40. Waldvogel HJ, Faull RLM, Williams NM, Dragunon M (1991) Differential sensitivity of calbindin/parvalbumin immunoreactive cells in the striatum to excitotoxins. Brain Res 546: 329-335.
41. Smith SK, Anderson HA, Yu G, Robertson AG, Allen SJ, et al. (2000) Identification of syntaxin 1A as a novel binding protein for presenilin-1. Brain Res. Mol. Brain Res. 31: 100-107.
42. Suga K, Tomiyama T, Mori H, Akagawa K (2004) Syntaxin 5 interacts with presenilin holoproteins, but not with their N- or C-terminal fragments and affects beta-amyloid peptide production. Biochem J 381: 619-628.
43. Upadhya SC, Hedge AN (2007) Role of ubiquitin proteasome system in Alzheimer's disease. BMC Biochemistry 8: S12.
44. Dhanasekaran M, Ren J (2005) The emerging role of co-enzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res 2: 447-459.
45. Beal MF (2004) Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's disease and coenzyme Q-10 as a potential treatment. J Bioenerg Biomembr 36: 381-386.
46. Nakase T, Naus CCG (2004) Gap junctions and neurological disorders of the central nervous system. Biochimica et Biophysica Acta 1662: 149-158.
47. Nagy JI, Li W, Hertzberg EL, Marotta CA (1996) Elevated connexin-43 immunoreactivity in Alzheimer's disease. Brain Res 717: 173-178.
48. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45: 675-688.
49. Nelson RL, Guo Z, Halagappa VM, Pearson M, Gray AJ, et al. (2007) Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp Neurol 205: 166-176.
50. Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S (2000) The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 275: 9572-9580.
51. Guo Y, Singleton PA, Rowshan A, Gucek M, Cole RN, et al. (2007) Quantitative proteomic analysis of human endothelial cell membrane rafts: Evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol Cell Proteomics 6: 689-696.
52. Donowitz M, Singh S, Salahuddin FF, Hogema BM, et al. (2007) Proteome of murine jejunal brush border membrane vesicles. J Proteome Res 6: 4068-4079.
53. Griffiths SD, Burthem J, Unwin RD, Holyoake TL, Melo JV, et al. (2007) The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia. Mol Biotechnol 36: 81-89.
54. Kassie F, Anderson LB, Higgins L, Pan Y, Matise I, et al. (2008) Chemopreventitive agents modulate expression profile of 4-(methylnitrosamino)-1(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice. Carcinogenesis 29: 610-619.
55. Graham RL, Sharma MK, Ternan NG, Weatherly DB, Tarleton RL, et al. (2007) A semi-quantitative GeLC-MS analysis of temporal proteome expression in the emerging nosocomial pathogen Ochrobactrum anthropi. Genome Biol 8: R110.